Drugs / TM30339
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00746824 | Aug 2008 → Jan 2009 | obesity disorder | 7TM Pharma A/S | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TM30339 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00746824 ↗ |
| Action | Activate | “Neuropeptide Y receptor type 4 agonist” CHEMBL3545106 ↗ |
| Route | Subcutaneous | “Repeated Subcutaneous Dose-range Study” NCT00746824 ↗ |
| Target | NPY4R | “Neuropeptide Y receptor type 4 agonist” CHEMBL3545106 ↗ |